4//SEC Filing
Hering David 4
Accession 0000899243-22-030183
CIK 0001832038other
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 4:28 PM ET
Size
5.0 KB
Accession
0000899243-22-030183
Insider Transaction Report
Form 4
Hering David
Chief Operating Officer
Transactions
- Purchase
Common Stock
2022-09-01$4.52/sh+8,000$36,160→ 8,000 total
Footnotes (1)
- [F1]The price in Column 4 is a weighted average purchase price. The prices actually paid ranged from $4.515 to $4.52. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
Adagio Therapeutics, Inc.
CIK 0001832038
Entity typeother
Related Parties
1- filerCIK 0001875613
Filing Metadata
- Form type
- 4
- Filed
- Aug 31, 8:00 PM ET
- Accepted
- Sep 1, 4:28 PM ET
- Size
- 5.0 KB